Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerase subunit gamma, catalytic subunit (POLG), is the primary enzyme responsible for replicating and repairing mitochondrial DNA in human cells. This large mitochondrial enzyme functions as the catalytic α (alpha) subunit of the heterotrimeric DNA polymerase gamma holoenzyme, which also includes a dimeric accessory β (beta) subunit that increases processivity and DNA binding. POLG exhibits polymerase activity for DNA synthesis, 3'-5' exonuclease activity for proofreading, and 5'-deoxyribose-phosphate lyase activity for base excision repair. Mutations in POLG are associated with a spectrum of mitochondrial diseases characterized by impaired energy metabolism, neurodegeneration, hepatopathy, and myopathy. Off-target inhibition or mutation of POLG can cause or exacerbate mitochondrial toxicities, especially in the context of certain drugs such as valproic acid or some nucleoside analogs, making POLG both a clinically significant disease gene and an important safety consideration in drug development.
Inhibition (by off-target drug effects leading to mitochondrial dysfunction); Mutation rescue (small molecules restoring mutant POLG function)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA polymerase subunit gamma, catalytic subunit (POLG).